For many years, clinical trials in oncology have almost exclusively catered to specific demographics when selecting trial subjects – namely White participants – a stark contrast to the reality ...

Leaders of the Common Sense Oncology initiative, launched 1.5 years ago as “a new patient-centered movement in cancer care,” outline principles for trial design, analysis, and reporting.

The open-access paper, titled ‘An Overview of Precision Oncology Basket and Umbrella Trials for Clinicians ... trials and outlining the key considerations for their successful design and ...

Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer Calibration-free odds type ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...